These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9626729)

  • 1. Three- to 5-year prospective follow-up of outcome in major depression.
    Van Londen L; Molenaar RP; Goekoop JG; Zwinderman AH; Rooijmans HG
    Psychol Med; 1998 May; 28(3):731-5. PubMed ID: 9626729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse of major depression after complete and partial remission during a 2-year follow-up.
    Pintor L; Gastó C; Navarro V; Torres X; Fañanas L
    J Affect Disord; 2003 Feb; 73(3):237-44. PubMed ID: 12547292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission and relapse after the first hospital admission in psychotic depression: a 4-year naturalistic follow-up.
    Naz B; Craig TJ; Bromet EJ; Finch SJ; Fochtmann LJ; Carlson GA
    Psychol Med; 2007 Aug; 37(8):1173-81. PubMed ID: 17335639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission and relapse in major depression: a two-year prospective follow-up study.
    Ramana R; Paykel ES; Cooper Z; Hayhurst H; Saxty M; Surtees PG
    Psychol Med; 1995 Nov; 25(6):1161-70. PubMed ID: 8637946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study.
    Conradi HJ; Ormel J; de Jonge P
    Psychol Med; 2011 Jun; 41(6):1165-74. PubMed ID: 20932356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for recurrence of depression five years after short term psychodynamic therapy.
    Koppers D; Peen J; Niekerken S; Van R; Dekker J
    J Affect Disord; 2011 Nov; 134(1-3):468-72. PubMed ID: 21676466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up?
    Pintor L; Torres X; Navarro V; Matrai S; Gastó C
    J Affect Disord; 2004 Oct; 82(2):291-6. PubMed ID: 15488260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment strategies in major depression: a 2-year prospective naturalistic follow-up after successful electroconvulsive therapy.
    Martínez-Amorós E; Cardoner N; Soria V; Gálvez V; Menchón JM; Urretavizcaya M
    J ECT; 2012 Jun; 28(2):92-7. PubMed ID: 22531201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Residual symptoms and recurrence in major depressive disorder].
    Spadone C; Corruble E
    Encephale; 2010 Dec; 36 Suppl 5():S108-11. PubMed ID: 21211628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
    Rush AJ; Trivedi MH; Wisniewski SR; Nierenberg AA; Stewart JW; Warden D; Niederehe G; Thase ME; Lavori PW; Lebowitz BD; McGrath PJ; Rosenbaum JF; Sackeim HA; Kupfer DJ; Luther J; Fava M
    Am J Psychiatry; 2006 Nov; 163(11):1905-17. PubMed ID: 17074942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy.
    Nierenberg AA; Petersen TJ; Alpert JE
    J Clin Psychiatry; 2003; 64 Suppl 15():13-7. PubMed ID: 14658986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.
    Sakurai H; Suzuki T; Yoshimura K; Mimura M; Uchida H
    Psychopharmacology (Berl); 2017 Aug; 234(16):2453-2461. PubMed ID: 28470399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results.
    Maina G; Rosso G; Bogetto F
    J Affect Disord; 2009 Apr; 114(1-3):200-7. PubMed ID: 18728001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Major depressive episode: a study of remission and relapses].
    Pintor L; Torres X; Navarro V; Gastó C
    Med Clin (Barc); 2002 Jan; 118(2):41-6. PubMed ID: 11809142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study.
    Bockting CL; Spinhoven P; Wouters LF; Koeter MW; Schene AH;
    J Clin Psychiatry; 2009 Dec; 70(12):1621-8. PubMed ID: 20141705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of subsyndromal symptoms emerging after remission of late-life depression.
    Kiosses DN; Alexopoulos GS
    Psychol Med; 2013 Feb; 43(2):341-50. PubMed ID: 22607988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.
    Bockting CLH; Klein NS; Elgersma HJ; van Rijsbergen GD; Slofstra C; Ormel J; Buskens E; Dekker J; de Jong PJ; Nolen WA; Schene AH; Hollon SD; Burger H
    Lancet Psychiatry; 2018 May; 5(5):401-410. PubMed ID: 29625762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approach to managing depression. Defining and measuring outcomes.
    Khullar A; McIntyre RS
    Can Fam Physician; 2004 Oct; 50():1374-80. PubMed ID: 15526874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.